The use of a microsomal in vitro assay to study phase I biotransformation of chlorobornanes (toxaphene (R)) in marine mammals and birds - Possible consequences of biotransformation for bioaccumulation and genotoxicity
Jp. Boon et al., The use of a microsomal in vitro assay to study phase I biotransformation of chlorobornanes (toxaphene (R)) in marine mammals and birds - Possible consequences of biotransformation for bioaccumulation and genotoxicity, COMP BIOC C, 121(1-3), 1998, pp. 385-403
Citations number
31
Categorie Soggetti
Pharmacology & Toxicology
Journal title
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
The factors determining the bioaccumulation of lipophilic compounds in wild
life are often poorly understood, partly because it is difficult to do in v
ivo experiments with animals such as marine mammals and birds. To evaluate
the role of phase I biotransformation in the bioaccumulation process of chl
orobornanes (toxaphene(R)), this was studied in in vitro assays with hepati
c microsomes of animals that could be sampled shortly after death. The capa
city of microsomes to metabolise a technical toxaphene mixture decreased in
the order Phoca vitulina (harbour seal) much greater than lagenorhynchus a
lbirostris (whitebeaked dolphin) congruent to Diomedea immutabilis (Laysan
albatross) > Physeter macrocephalus (:sperm whale). Harbour seal microsomes
metabolised the chlorobornane (CHB) congeners CHB-32 and CHB-62; whitebeak
ed dolphin and Laysan albatross microsomes only metabolised CHB-32. Metabol
ism of CHB-26 and CHB-50 was never observed. The negative chemical ionisati
on (NCI -) mass spectra of some of the hydroxylated metabolites were obtain
ed. The number of peaks in the toxaphene residues of wildlife extracts decr
eased in the order of increasing in-vitro biotransformation capacity. Thus,
the results of the in vitro assays and residue analysis were in accordance
, although assays with microsomes of more individuals of the same species a
re required for a more general conclusion at the species level. Finally, th
e effect of in vitro biotransformation was evaluated in terms of the genoto
xic potential using the Mutatox(R) assay. Only technical toxaphene and CHB-
32 were genotoxic in the direct assay, whereas the addition of rat S9 fract
ion or microsomes of harbour seal and albatross decreased the genotoxic res
ponse. Thus, organisms with a low ability to metabolise chlorobornanes, suc
h as whales, may be most affected by the carcinogenic properties of toxaphe
ne. A hypothetical reaction which fits the experimental results is discusse
d. Based on these results it is concluded that in vitro assays with microso
mes of wildlife animals which died a natural cause can act as a valuable to
ol to assess the occurrence and effects of phase I metabolism. Some precaut
ions are discussed, that should be taken to reduce the chance of false nega
tive results. (C) 1998 Published by Elsevier Science Inc. All rights reserv
ed.